Results 271 to 280 of about 1,853,303 (361)

Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritis. [PDF]

Lupus Sci Med
Villalobos Navarro A, Xipell M, Hernández EG, Valjalo R, Contreras F, Ruiz de Arechavaleta A, Segura P, Miranda D, Ávila E, Hidalgo MJ, Diaz Garcia JD, Pérez FP, Valderrama Ávila D, Gil Arredondo MI, Guillén E, Cervera R, Espinosa G, Pereira A, Blasco M, Quintana LF.   +19 more
europepmc   +1 more source

Journal of a residence in Chile, during the year 1822. And a voyage from Chile to Brazil in 1823

Maria Callcott, William R. Yates, Judas Tadeo de Reyes   +2 more
openalex   +2 more sources

La introducción del salmon en Chile,

, 1907
Pedro. from old catalog Golusda
openalex   +2 more sources

A scoping review of disease‐modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice

British Journal of Clinical Pharmacology, EarlyView.
Aims Adherence to disease‐modifying antirheumatic drugs (DMARDs) has been associated with improved treatment outcomes, but how adherence is reported ranges between studies. We therefore aimed to determine how nonadherence to DMARDs used to treat rheumatoid arthritis (RA) has been measured and to report the nonadherence rate with each measure identified.
Lauren Fraser, Nagham Ailabouni, Lisa Kalisch Ellett, Jiun Ming Tan, Anthea Freeman, Susanna M. Proudman, Emily Reeve, Michael D. Wiese   +7 more
wiley   +1 more source

Network-based risk assessment of ship-mediated dispersal of non-native species across Chilean and international ports. [PDF]

Sci Rep
Pinochet J, Rivera R, Brante A.
europepmc   +1 more source

Peronism in Chile [PDF]

The Hispanic American Historical Review, 1967
openaire   +2 more sources

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon‐like peptide‐1 and glucagon receptor in healthy subjects

British Journal of Clinical Pharmacology, EarlyView.
Aims Glucagon‐like peptide‐1 (GLP‐1) and glucagon dual receptor agonists are in clinical development for a range of metabolic conditions, including type 2 diabetes and obesity. The cardiovascular actions at these receptors are well studied, but less is known about their combination.
James Goodman, Victoria E. Parker, Carmel M. McEniery, Giovanni Di Stefano, Annette Hubsch, Evangelia Vamvaka, Jo Helmy, Fotini Kaloyirou, Navazh Jalaludeen, Peter Barker, Lutz Jermutus, Joseph Cheriyan, Philip Ambery, Ian B. Wilkinson   +13 more
wiley   +1 more source

Real-World Data on Inotuzumab Ozogamicin for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A GRELAL-Chile Study. [PDF]

Cancer Med
Espinoza M, Rojas-Vallejos J, Rodríguez N, Guerrero G, López M, Aranguiz N, Conte G, Samaniego F, Quinteros N, Astete D, Carcamo L, Flores C, Huerta X, Chandía M, Valenzuela J, Navarrete M, Flores Y, Larrazabal A, Zapata E, Jerez J.   +19 more
europepmc   +1 more source

Kelps on the move: Potential future distribution areas in the face of climate change, on the Pacific coast of South America. [PDF]

PLoS One
Duarte M, Sanhueza N, Vásquez JA, Tala F, González AV.   +4 more
europepmc   +1 more source

Activism in the arts: Co‐researching cultural inequalities with young people during the COVID‐19 pandemic

British Educational Research Journal, EarlyView.
Abstract This paper explores the growing influence of young people's activism in UK museums and its educational implications. It draws on a five‐year collaborative programme (2019–2023) with young people of colour (16–28) in a university museum setting, focusing on a Young Collective established to address cultural inequalities.
Sadia Habib
wiley   +1 more source